For patients with a high CV risk (SCORE2-Diabetes > 10%) but without ASCVD or target organ damage (TOD), metformin is recommended, with class IIb recommendations for the use of SGLT2is and GLP-1 RAs [19]. The gene discussed is GLP1R; the disease is diabetes mellitus.